HT, H., AQM, A., N, A., & J, S. (2024). Glycemic impact of gabapentin and Nucleo C.M.P in metformin-controlled diabetic patients: A case report. SAGE open medical case reports, 12, 2050313X241265072. https://doi.org/10.1177/2050313X241265072
Chicago Style (17th ed.) CitationHT, Hashim, Alhatemi AQM, Aji N, and Shah J. "Glycemic Impact of Gabapentin and Nucleo C.M.P in Metformin-controlled Diabetic Patients: A Case Report." SAGE Open Medical Case Reports 12 (2024): 2050313X241265072. https://doi.org/10.1177/2050313X241265072.
MLA (9th ed.) CitationHT, Hashim, et al. "Glycemic Impact of Gabapentin and Nucleo C.M.P in Metformin-controlled Diabetic Patients: A Case Report." SAGE Open Medical Case Reports, vol. 12, 2024, p. 2050313X241265072, https://doi.org/10.1177/2050313X241265072.